MXC: $0.05
What We Produce


MGC Pharma operates in several different segments of Phytocannabinoid-based medicines.

MGC Pharma applies high standards of QA and QC to segments of the Phytomedicine industry, allowing us to meet and exceed Good Manufacturing Practice (GMP) and GACP protocols globally.  Currently, the Company has Investigational Medicinal Products (IMP), being CannEpil® and CogniCann®, along with phytotherapeutics from our white label products.

Are you in Australia or Brazil?

NoYes